Lv2
148 积分 2024-06-03 加入
HSR25-154: Treatment Patterns and Prognosis of Patients With HER2-Negative Early Breast Cancer and Germline Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2
1个月前
已关闭
Expression of Concern: ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage
1个月前
已完结
Suppression of BRAC1 facilitates kidney regeneration
1个月前
已完结
Concurrent inhibition of FLT3 and sphingosine kinase-1 triggers synergistic cytotoxicity in midostaurin resistant FLT3-ITD positive acute myeloid leukemia cells via blocking FLT3/STAT5A signaling to induce apoptosis
1个月前
已完结
Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy
1个月前
已完结
DNAR special issue: DNA damage responses and neurological disease The DNA damage response and neurological disease
2个月前
已完结
DNAR special issue: DNA damage responses and neurological disease The DNA damage response and neurological disease
2个月前
已完结
Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes
4个月前
已完结
Corrigendum to “SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer” [Cancer Lett. 524 (2022) 268–283]
5个月前
已完结
DNAR special issue: DNA damage responses and neurological disease The DNA damage response and neurological disease
5个月前
已完结
皖公网安备34019202002308
